JF Schlaak

11.1k total citations
172 papers, 7.8k citations indexed

About

JF Schlaak is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, JF Schlaak has authored 172 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hepatology, 69 papers in Epidemiology and 52 papers in Immunology. Recurrent topics in JF Schlaak's work include Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (46 papers) and Liver Disease Diagnosis and Treatment (39 papers). JF Schlaak is often cited by papers focused on Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (46 papers) and Liver Disease Diagnosis and Treatment (39 papers). JF Schlaak collaborates with scholars based in Germany, China and United States. JF Schlaak's co-authors include Guido Gerken, Mengji Lu, Ruth Broering, Karl‐Hermann Meyer zum Büschenfelde, Martin Trippler, Markus F. Neurath, Bernhard Fleischer, Ulf Dittmer, Dongliang Yang and Michael Roggendorf and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

JF Schlaak

170 papers receiving 7.6k citations

Peers

Countries citing papers authored by JF Schlaak

Since Specialization

Citations

This map shows the geographic impact of JF Schlaak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JF Schlaak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JF Schlaak more than expected).

Fields of papers citing papers by JF Schlaak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JF Schlaak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JF Schlaak. The network helps show where JF Schlaak may publish in the future.

Co-authorship network of co-authors of JF Schlaak

This figure shows the co-authorship network connecting the top 25 collaborators of JF Schlaak. A scholar is included among the top collaborators of JF Schlaak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JF Schlaak. JF Schlaak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pattern Recognition Receptors and Liver Failure 2019 ·Critical Reviews in Immunology ·Jun Wu, (unknown), Jia Li, Xiaoli Yang, Xin Zhen, JF Schlaak, (unknown), Mengji Lu	5
2	Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients 2014 ·Journal of Medical Virology ·Antonios Katsounas, Joseph J. Rasimas, JF Schlaak, Richard A. Lempicki, Donald L. Rosenstein, Shyam Kottilil	2
3	768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS) 2013 ·Journal of Hepatology ·John Asger Petersen, R Heyne, (unknown), JF Schlaak, (unknown), Christoph Eisenbach, H Hartmann, Manfred Wiese, (unknown), (unknown), C John, M. Leuschner, Christian Trautwein, G Felten, (unknown), W. Kŕause, (unknown), Tobias Warger, D Hüppe	5
4	A Combination of α-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma 2013 ·Digestion ·Judith Ertle, Dominik Heider, Marc Wichert, (unknown), (unknown), Philip Hilgard, Guido Gerken, JF Schlaak	87
5	A New Model to Estimate Prognosis in Patients with Hepatocellular Carcinoma after Yttrium-90 Radioembolization 2013 ·PLoS ONE ·Zhihong Weng, Judith Ertle, Shaoping Zheng, Thomas C. Lauenstein, Stefan Müeller, Andreas Bockisch, Guido Gerken, Dongliang Yang, JF Schlaak	19
6	High interferon‐stimulated gene ISG‐15 expression affects HCV treatment outcome in patients co‐infected with HIV and HCV 2013 ·Journal of Medical Virology ·Antonios Katsounas, Jonathan J. Hubbard, (unknown), Xiaozhen Zhang, Diana R. Dou, Bhavana Shivakumar, Sophie L. Winter, JF Schlaak, Richard A. Lempicki, Henry Masur, Michael A. Polis, Shyam Kottilil, Anu Osinusi	12
7	Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response 2012 ·Hepatology ·Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard A. Lempicki, Eva Herrmann, Alexander Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, JF Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis, Shyam Kottilil	55
8	ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV 2012 ·Journal of Medical Virology ·Anu Osinusi, Susanna Naggie, Seerat Poonia, Martin Trippler, Zonghui Hu, Emily K. Funk, JF Schlaak, Dawn Fishbein, Henry Masur, Michael A. Polis, Shyam Kottilil	12
9	CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus 2011 ·International Reviews of Immunology ·Antonios Katsounas, JF Schlaak, Richard A. Lempicki	30
10	Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis 2010 ·International Journal of Cancer ·Judith Ertle, Alexander Dechêne, Jan‐Peter Sowa, Volker Penndorf, Kerstin Herzer, Gernot Kaiser, JF Schlaak, Guido Gerken, Wing‐Kin Syn, Ali Canbay	383
11	Imposanter Befund einer Melanosis coli nach jahrzehntelangem Abusus von Anthrachinonderivaten – ein Risikofaktor für kolorektale Neoplasien? 2009 ·Zeitschrift für Gastroenterologie ·(unknown), Robert J. Klein, JF Schlaak, K. Metz, G. Dobos, Jost Langhorst	6
12	581 HBV SUPPRESSES TLR-MEDIATED INNATE IMMUNE RESPONSES IN MURINE PARENCHYMAL AND NON-PARENCHYMAL LIVER CELLS 2008 ·Journal of Hepatology ·Jun Wu, Zhongji Meng, Martin Trippler, Ruth Broering, (unknown), (unknown), Ehydel Castro, (unknown), Ulf Dittmer, (unknown), Michael Roggendorf, Guido Gerken, Mengji Lu, JF Schlaak	2
13	Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration 2008 ·World Journal of Gastroenterology ·Jan‐Peter Sowa, Jan Best, Tamás Benkö, Maximillian Bockhorn, Yanli Gu, (unknown), (unknown), (unknown), Guido Gerken, Ursula Rauen, JF Schlaak	20
14	Erythropoietin Treatment Improves Liver Regeneration and Survival in Rat Models of Extended Liver Resection and Living Donor Liver Transplantation 2008 ·Transplantation ·Maximilian Bockhorn, Christian D. Fingas, Ursula Rauen, Ali Canbay, Georgios C. Sotiropoulos, Ulrich H. Frey, (unknown), J. Wohlschläger, Christoph E. Broelsch, JF Schlaak	22
15	Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells 2003 ·The Journal of Immunology ·Catharien M. U. Hilkens, JF Schlaak, Ian M. Kerr	94
16	Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease 1999 ·Gut ·Markus F. Neurath, (unknown), Matthew Peters, Frank Krummenauer, K-H Meyer zum Büschenfelde, JF Schlaak	136
17	The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response 1999 ·Journal of Hepatology ·JF Schlaak, (unknown), H Löhr, Guido Gerken, (unknown)	27
18	Anti-Inflammatory Cytokine Release by Alveolar Macrophages in Pulmonary Sarcoidosis 1996 ·American Journal of Respiratory and Critical Care Medicine ·Gernot Zissel, J Homolka, JF Schlaak, Max Schlaak, Joachim Müller‐Quernheim	83
19	Liver‐infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA‐restriction and functional significance 1996 ·Liver International ·H Löhr, JF Schlaak, (unknown), Hans‐Peter Dienes, (unknown), Guido Gerken	33
20	Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants 1995 ·Hepatology ·H Löhr, Wolfgang Weber, JF Schlaak, Bernd Goergen, Karl-Hermann Meyer zum Büschenfelde, Guido Gerken	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact